A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use Disorder

OBJECTIVE: The oral formulation of the opioid antagonist naltrexone has shown limited effectiveness for treatment of opioid use disorder due to poor adherence. Long-acting injection naltrexone (XR-naltrexone), administered monthly, circumvents the need for daily pill taking, potentially improving ad...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Psychiatry
Main Authors: Sullivan, Maria A., Bisaga, Adam, Pavlicova, Martina, Carpenter, Kenneth M., Choi, C. Jean, Mishlen, Kaitlyn, Levin, Frances R., Mariani, John J., Nunes, Edward V.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6358483/
https://ncbi.nlm.nih.gov/pubmed/30336703
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1176/appi.ajp.2018.17070732
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados